Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to Coherent Market Insights, the global tissue engineering market is estimated to be valued at US$ 9,436.0 million in 2022 and is...
The Cleveland-based regenerative medicine company announced Thursday, Aug. 4, that it has named turnaround consultant Kasey Rosado to the interim CFO role. Ivor Macleod, the company's former CFO, left Athersys on June 30 as part of a restructuring announced in early June that is cutting the workforce by 70%.
The Cleveland biotechnology company said it will 'evaluate alternative financing options to support continuing operations' following an announcement of the termination of its $100 million equity purchase agreement with Aspire.
A look at the most prominent Northeast Ohio business stories of the past week.
The Cleveland-based regenerative medicine company, which is undertaking cost-cutting and restructuring efforts, cut the size of the board of directors in half ahead of the annual meeting of shareholders. That meeting will take place on Thursday, July 28.